Teva (TEVA) is up 19.2%, or $3.17 to $19.68.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Teva, Sanofi report RELIEVE UCCD Phase 2b study met primary endpoints
- Teva, Sanofi announce results from Phase 2b RELIEVE UCCD study
- Monte Rosa Therapeutics appoints Hughes to board of directors
- Teva call volume above normal and directionally bullish
- Teva announces new patient access program with Direct Relief